STERIS - STE Enterprise Value-to-Revenue Multiple

STERIS (STE) - corporate logo

The enterprise value-to-revenue ratio helps illustrate the strategy of STERIS plc (STE) as a global sterilization leader with predictable cash flow. This metric confirms the company's independence from economic cycles due to the critical importance of its services for clinics. Market capitalization growth is supported by synergies with Cantel Medical and stringent medical regulations, with the current level standing at 4260.83.

STE: STERIS PLC Company Value to Revenue 11/23/2025 - 11/20/2026

STE (STERIS Group): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental valuation:STERIS plc (STE)
Original product of STERIS Corporation

The EV/Sales (co) ratio measures the total value of a business relative to its revenue, excluding the impact of debt load to determine an objective market valuation. For STERIS (STE), with its patent monopoly in sterilization and strict FDA compliance, this metric confirms the fundamental value of a high barrier to entry. By analyzing the dynamics of the company's value relative to revenue, an investor can distinguish organic business resilience from capital stagnation.

Competitor analysis for STERIS plc

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio West Pharmaceutical Services|Company Value to Revenue Ratio BAX (Baxter International)|Enterprise Value-to-Revenue Ratio Masimo (MASI)|Stevanato Group - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio Teleflex Inc. TFX|Enterprise Value-to-Revenue Coefficient MMSI (Merit Medical Systems, Inc.)|NVST - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio ICU Medical Corp ICUI|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple